This site is intended for health professionals only
Tuesday 18 December 2018
Share |

Zilico Ltd cervical cancer diagnostics tool

Related articles

Delays in taking new cancer drugs through clinical trials and getting them approved for use mean NHS patients are waiting longer to access them, a report by the Institute of Cancer Research (ICR) finds.
Zilico Ltd will present its pioneering cervical cancer diagnostics tool at Medica 2012 - the world’s premier healthcare exhibition.
The British company’s innovative system, which is due to be launched in 2013, offers quicker more accurate detection of cervical dysplasia in real time, removing several weeks of waiting time for diagnosis.

Ads by Google